|
|
楼主 |
发表于 2025-2-6 15:36:45
|
显示全部楼层
本帖最后由 NatureBoy 于 2025-2-6 16:03 编辑
% Z2 m: N6 U; O- D% x
' ^$ A0 H" K$ h今年的ISC大会Late-Breaking Science（重磅研究）已经出炉，国内单位入选情况
6 U, R1 C) _, t5 d
2 e& `& v0 ]/ R; {( F- E! L1 ?" eLB2. TransRadial versus transfemoral Arterial access for CErebral angiography' x/ c3 }( ?* h& \; z8 y% V
Wei Ni, Huashan Hospital, Fudan University, Shanghai, China
5 S; R5 e( k: _0 M# {$ G# V2 y, f% y+ D$ d$ j4 G
LB17. Intensive Blood Pressure Lowering After Thrombectomy in Ischemic Stroke Patients-A Randomized Clinical Trial4 k( W/ I6 W: M+ H |
Xuening Zhang, West China Hospital, Sichuan University, Chendu, China
& X o1 T% l/ d- ? |$ G. S7 M4 S2 j3 g/ g
LB38. Intra-arterial Tenecteplase thrombolysis for acute LVO after successful mechanical thrombectomy recanalization (ANGEL-TNK) — A Multicenter, Prospective, Randomized, Open-label, Blinded End-point Trial
2 e% l8 c( |! Y2 h0 aMiao Zhongrong, Beijing Tiantan Hospital, Beijing, China
- g, Y0 a3 I2 Y- x. d# }; J
3 @8 ^5 L' x, z4 K* K' ~LB39. The Optimal Dosage of ADjunctive Intra-Arterial Tenecteplase following Successful Endovascular Thrombectomy in Patients with Large Vessel Occlusion Acute Ischemic Stroke (DATE) Trail/ u! J2 y# h' T) l' m7 \
Xianhua Hou, The First Affiliated Hospital, Army Medical University, Chongqing, China
; x! X( l0 k$ @/ K$ i0 U3 ^7 r% }8 J
LB41. Treatment with intravenous alteplase in ischemic stroke patients with onset time between 4.5 and 24 hours# }) L* v O" b) j
Min Lou, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China9 @/ l4 o# T. _7 H* G% b7 ?& W
! H+ ]( V" ~% a1 c
LB42. Intra-arterial Alteplase for Acute Ischemic Stroke After Mechanical Thrombectomy (PEARL): A Multicenter Randomized Trial, z7 N# n% G; H0 d% J
Yamei Tang, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China, i9 h) O4 A& C s, B, F4 w
* O: e% b/ v' j1 u6 p8 u" u4 C0 \
LB44. Liraglutide in Acute Minor Ischemic Stroke or High-risk Transient Ischemic Attack Patients with Type 2 Diabetes Mellitus (LAMP): A Randomized Clinical Trial Y3 z( E) s. S# n1 m, D
Huili Zhu, The First Affiliated Hospital of Jinan University, Guangzhou, China
% m; c6 _, X w( a. s# ]$ q' G% W7 u- N+ m) f
LB45. BXOS110 for Acute Ischemic Stroke Treatment (BEST): A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial
- Z0 v5 _" I* M+ m! MYarong Ding, Beijing Tiantan Hospital, Beijing, China
' o/ M' _- F: C0 B$ D
! V0 T$ {2 t: R5 l# W* t1 i祝贺以上单位！
% a, i5 l0 K/ P) H0 w: |0 P |
|
发表于 2025-2-6 15:11:41
发表于 2025-2-6 15:40:38
